Test 1: answer key

Question 1 · 2 marks · Strategic Intent - Vision and Mission · medium

Scenario. Aethel Healthcare Ltd. operates pathology laboratories, imaging centres and diagnostic sample-collection facilities. Its proposed vision statement is to become India's most trusted neighbourhood diagnostic network by 2035, making dependable diagnosis accessible in every district. Its proposed mission statement is to deliver reliable pathology and imaging results with compassionate care, timely communication and accessible sample collection so that patients and clinicians can make informed healthcare decisions. The company's stated core values are scientific integrity, patient dignity, confidentiality and continuous improvement. Recently, a regional laboratory manager discovered deviations in quality-control readings. The operations team was under pressure to meet a quarterly turnaround-time target and was considering releasing affected reports before resolving the deviations. At the same time, the board is considering expansion into three additional states, a differentiated premium diagnostic offering for urban hospitals, and revised laboratory-level operating procedures.

Which interpretation of Aethel Healthcare Ltd.'s proposed vision and mission statements is most appropriate?

1. The first statement is a vision because it describes the desired future position; the second is a customer-focused mission because it explains the present business purpose and the value delivered to patients and clinicians. (correct answer)
2. The first statement is a mission because it mentions geographic expansion; the second is a vision because it refers to informed healthcare decisions.
3. Both statements are vision statements because both describe broad organisational aspirations rather than present activities.
4. The second statement is a product-focused mission because it names pathology and imaging services, irrespective of its reference to patient and clinician needs.

Answer: A — The first statement is a vision because it describes the desired future position; the second is a customer-focused mission because it explains the present business purpose and the value delivered to patients and clinicians.

Working. Step 1: Identify the time orientation of the first statement. It describes a desired position by 2035, so it is a vision. Step 2: Identify the purpose of the second statement. It explains present diagnostic services, patient care, communication and the needs of clinicians. Step 3: Classify the second statement as a customer-focused mission. Thus, the correct combination is vision followed by customer-focused mission.

Explanation. Option (a) is correct. A vision describes where an organisation wants to reach in the future and communicates its desired position. The first statement sets out Aethel's aspiration for 2035. A mission explains what business the organisation undertakes, its present capabilities, its activities and its customer focus. The second statement explains the diagnostic services provided and the outcomes intended for patients and clinicians. Option (b) reverses the concepts: a future desired position is a vision, not a present business mission. Option (c) ignores the distinction between future aspirations and present purpose. Option (d) incorrectly classifies a statement merely from the products mentioned. The emphasis on helping patients and clinicians make informed decisions makes the mission customer-focused rather than narrowly product-focused.

Where it goes wrong. The presence of a product or service name in a mission statement does not automatically make it product-focused. Examine whether the statement primarily explains what the organisation produces or the needs and benefits it fulfils for its customers.

Authority. Chapter 1: Introduction to Strategic Management, Section 1.5 Strategic Intent - Vision and Mission; Chapter 1: Introduction to Strategic Management, Section 1.5.1 Vision; Chapter 1: Introduction to Strategic Management, Section 1.5.2 Mission

Question 2 · 2 marks · Strategic Intent - Values · medium

Aethel Healthcare's laboratory manager discovers unexplained deviations in quality-control readings, but the operations team is under pressure to meet turnaround-time targets. Which management response most faithfully reflects the company's stated core values?

1. Release the reports immediately with a general disclaimer and resolve the quality-control issue later.
2. Withhold affected reports until the deviation is investigated, repeat the necessary quality checks, escalate the issue and transparently communicate the resulting delay. (correct answer)
3. Adjust the quality-control records to match earlier acceptable readings so that the turnaround-time target is not missed.
4. Transfer the affected tests to an unapproved external laboratory without informing the treating clinicians, thereby avoiding an internal delay.

Answer: B — Withhold affected reports until the deviation is investigated, repeat the necessary quality checks, escalate the issue and transparently communicate the resulting delay.

Working. Step 1: Identify the applicable core values: scientific integrity, patient dignity, confidentiality and continuous improvement. Step 2: Determine which response protects the reliability of test results and patient interests. Step 3: Investigating the deviation and repeating checks ensures scientific reliability. Step 4: Transparent communication maintains trust and patient dignity. Therefore, option (b) is consistent with the stated value system.

Explanation. Option (b) is correct. The organisation's stated values include scientific integrity, patient dignity, confidentiality and continuous improvement. Investigating the deviation, repeating the necessary checks and communicating transparently protects the reliability of diagnostic information and patient interests. Option (a) gives priority to a performance target despite unresolved quality concerns, thereby compromising scientific integrity. Option (c) is an intentional distortion of quality-control information and is fundamentally inconsistent with integrity. Option (d) compromises transparency and proper clinical communication by using an unapproved testing arrangement without informing the treating clinicians. Core values guide decisions even when short-term economic or operational considerations create pressure.

Where it goes wrong. Do not confuse measurable operational targets, such as turnaround time, with core values. Values are deep-rooted principles guiding decisions and cannot be compromised merely for short-term economic or operational convenience.

Authority. Chapter 1: Introduction to Strategic Management, Section 1.5 Strategic Intent - Values/Value System

Question 3 · 2 marks · Strategic Levels in Organisations · medium

Aethel Healthcare's board proposes three strategic actions: (i) expansion of the organisation into three additional states across its service businesses, (ii) positioning its urban diagnostic division through differentiated premium services for hospital groups, and (iii) introducing revised laboratory-level operating procedures and staff schedules. Which classification of the three actions is correct?

1. Corporate level, Business level and Functional level respectively, with the first action classified as Business level.
2. Corporate level, Functional level and Business level respectively.
3. Corporate level, Business level and Functional level respectively. (correct answer)
4. Functional level, Business level and Corporate level respectively.

Answer: C — Corporate level, Business level and Functional level respectively.

Working. Step 1: Expansion across states and service businesses concerns the entire organisation's scope and resource allocation, so it is Corporate level. Step 2: Premium positioning of the urban diagnostic division determines how that business competes, so it is Business level. Step 3: Laboratory procedures and staff scheduling concern operational functions, so they are Functional level. Therefore, the correct sequence is Corporate, Business and Functional.

Explanation. Option (c) is correct. Corporate-level strategy concerns the organisation as a whole, including its overall direction, business scope, expansion and allocation of resources. Business-level strategy concerns how a particular strategic business unit competes in its chosen market. Functional-level strategy relates to the specific operating functions and activities through which corporate and business strategies are executed. Option (a) contains an inconsistent classification: its stated sequence is not supported by its explanation of the first action. Option (b) wrongly treats competitive positioning as a functional-level decision and laboratory operating procedures as business-level strategy. Option (d) misclassifies overall geographic expansion and laboratory procedures. The three levels are related but have distinct areas of strategic responsibility.

Where it goes wrong. The scale of an action alone does not determine its strategic level. The important distinction is whether the decision determines the organisation's overall scope, the competitive approach of a particular business, or the execution of a specific organisational function.

Authority. Chapter 1: Introduction to Strategic Management, Section 1.6 Strategic Levels in Organisations - Corporate Level; Chapter 1: Introduction to Strategic Management, Section 1.6 Strategic Levels in Organisations - Business Level; Chapter 1: Introduction to Strategic Management, Section 1.6 Strategic Levels in Organisations - Functional Level

Question 4 · 2 marks · External Environment - Porter's Five Forces · medium

Scenario. Surya Diagnostics Ltd. operates a chain of pathology laboratories in several Indian cities. It faces competition from other established diagnostic laboratory chains. However, its industry environment is changing. For routine glucose monitoring, patients increasingly use home-monitoring devices and continuous glucose-monitoring systems that reduce their need for repeated laboratory visits. Large hospital groups and corporate healthcare networks account for approximately 40% of Surya's institutional testing volume. These buyers invite tenders from several accredited diagnostic providers, negotiate volume-based pricing and can shift routine testing orders with relatively low switching costs. On the supply side, most specialised diagnostic assays require proprietary reagents compatible with the installed automated analysers. Only two major suppliers provide these reagents, suitable alternative products are unavailable, and changing suppliers would involve substantial equipment validation and operational costs. The management has commissioned an industry analysis using Porter's Five Forces.

Which competitive force is most directly represented by patients increasingly using home-monitoring devices and continuous glucose-monitoring systems instead of repeatedly visiting pathology laboratories for routine glucose monitoring?

1. Rivalry among existing firms, because the devices represent another pathology laboratory chain.
2. Bargaining power of suppliers, because manufacturers of glucose-monitoring devices supply equipment to laboratories.
3. Bargaining power of buyers, because patients decide how frequently they purchase laboratory services.
4. Threat of substitutes, because alternative products perform the same or nearly the same monitoring function and can reduce demand for laboratory visits. (correct answer)

Answer: D — Threat of substitutes, because alternative products perform the same or nearly the same monitoring function and can reduce demand for laboratory visits.

Working. Step 1: Identify the industry's existing service: routine laboratory-based glucose monitoring. Step 2: Identify the alternative: home-monitoring devices and continuous glucose-monitoring systems. Step 3: Assess whether the alternative performs the same or nearly the same function for the customer. It does for routine monitoring needs. Step 4: Determine the competitive implication: fewer repeat laboratory visits and potential pressure on laboratory demand and prices. The applicable force is the threat of substitutes.

Explanation. Option (d) is correct. The threat of substitutes arises when products or services from other industries perform the same or nearly the same function as the industry's existing offering. Home-monitoring devices can fulfil part of the routine glucose-monitoring need without a repeated laboratory visit. This may constrain laboratory demand and pricing. Option (a) is incorrect because another pathology laboratory offering similar tests would normally be an existing competitor, not a substitute from another solution category. Option (b) relates to the bargaining power of suppliers and does not explain why patients may choose an alternative monitoring method. Option (c) concerns the bargaining power of buyers, whereas the central fact in the question is the emergence of an alternative product performing a similar function. These forces must be distinguished even though one market development can affect more than one force.

Where it goes wrong. Do not automatically classify every alternative provider as a substitute. A competing pathology laboratory is generally part of rivalry among existing firms. A substitute is an alternative product or service that satisfies the same or nearly the same customer need through a different offering.

Authority. Chapter 2: Strategic Analysis: External Environment, Section 2.5.1 Porter's Five Forces Model - V. Threat of Substitutes

Question 5 · 2 marks · External Environment - Porter's Five Forces · hard

Surya Diagnostics' institutional buyers account for approximately 40% of testing volume. They purchase large volumes, possess information about alternative providers, invite competitive tenders and can shift routine testing orders at relatively low cost. Which conclusion regarding buyer bargaining power is most appropriate?

1. Buyer bargaining power is strong because large, concentrated buyers can use volume, alternative suppliers and relatively low switching costs to negotiate lower prices and better services. (correct answer)
2. Supplier bargaining power is strong because the hospital groups purchase large quantities of diagnostic reagents from Surya.
3. Buyer bargaining power is weak because diagnostic testing is always critical and therefore large hospitals cannot negotiate prices.
4. Rivalry among existing firms is the only relevant force because tendering automatically makes all bargaining power factors irrelevant.

Answer: A — Buyer bargaining power is strong because large, concentrated buyers can use volume, alternative suppliers and relatively low switching costs to negotiate lower prices and better services.

Working. Step 1: Identify the buyers: hospital groups and corporate healthcare networks. Step 2: Evaluate their relative purchasing size: they represent 40% of institutional testing volume. Step 3: Evaluate their alternatives: several diagnostic providers participate in tenders. Step 4: Evaluate switching costs: relatively low switching costs make changing providers easier. Step 5: Evaluate their bargaining position: large volume, available alternatives and low switching costs collectively indicate strong buyer bargaining power.

Explanation. Option (a) is correct. The ICAI framework identifies buyer knowledge, the scale of expenditure, buyer concentration relative to suppliers and the availability of alternatives as important determinants of buyer bargaining power. Surya's large institutional buyers have considerable purchasing volume, several alternative service providers and low switching costs. These conditions strengthen their negotiating position over price and service levels. Option (b) confuses the buyers of diagnostic services with the suppliers of laboratory inputs. Option (c) ignores the substantial purchasing power arising from the buyers' size and their access to alternative providers. The critical nature of some tests does not automatically eliminate institutional bargaining power in this scenario. Option (d) incorrectly assumes that rivalry and buyer bargaining power are mutually exclusive. Tendering can intensify rivalry while also strengthening buyer leverage.

Where it goes wrong. Do not classify a party by its identity alone. Hospitals are buyers of Surya's diagnostic services, while reagent manufacturers are suppliers to Surya. Also, the fact that a service is important does not automatically mean buyer bargaining power is weak.

Authority. Chapter 2: Strategic Analysis: External Environment, Section 2.5.1 Porter's Five Forces Model - II. Bargaining Power of Buyers

Question 6 · 2 marks · External Environment - Porter's Five Forces · hard

Surya Diagnostics depends on proprietary diagnostic reagents from only two major suppliers. The reagents are critical to its testing operations, compatible alternatives are unavailable, and changing suppliers would involve significant validation and operational costs. Which inference is most appropriate?

1. Supplier bargaining power is weak because Surya owns the laboratory analysers and therefore controls reagent prices.
2. Supplier bargaining power is strong because suppliers are concentrated, their inputs are essential, substitutes are unavailable and switching costs are high. (correct answer)
3. Buyer bargaining power is necessarily strong because reagent manufacturers sell to only two major diagnostic chains.
4. The threat of new entrants is strong because proprietary reagents make the establishment of a new diagnostic laboratory easier.

Answer: B — Supplier bargaining power is strong because suppliers are concentrated, their inputs are essential, substitutes are unavailable and switching costs are high.

Working. Step 1: Identify the suppliers: two major specialised reagent manufacturers. Step 2: Examine supplier concentration: very limited number of suppliers. Step 3: Examine input importance: reagents are essential for laboratory testing. Step 4: Examine substitutes: no compatible alternative is available. Step 5: Examine switching costs: supplier changes require substantial validation and operating expenditure. Step 6: These factors collectively indicate strong supplier bargaining power.

Explanation. Option (b) is correct. Supplier bargaining power increases when suppliers provide specialised inputs, are limited in number, supply products crucial to the buyer's operations and face little effective substitution. High switching costs further strengthen supplier leverage. All these conditions exist in Surya's case. Option (a) is incorrect because ownership of analysers does not eliminate dependence on proprietary compatible reagents. Option (c) wrongly classifies the position of reagent manufacturers as buyer power. The relevant suppliers are the reagent manufacturers, and their concentration increases their bargaining strength over laboratory operators. Option (d) reverses the effect of proprietary reagents. Dependence on specialised inputs may create operational difficulties and barriers for potential entrants rather than automatically facilitating entry.

Where it goes wrong. The existence of a large buyer does not automatically mean it has bargaining power over every supplier. Examine the availability of substitutes, input importance, supplier concentration and switching costs. Proprietary inputs can create significant supplier leverage even when the customer is a large organisation.

Authority. Chapter 2: Strategic Analysis: External Environment, Section 2.5.1 Porter's Five Forces Model - III. Bargaining Power of Suppliers

Question 7 · 2 marks · Strategic Analysis: External Environment - Competitor Analysis and Strategic Groups · medium

Scenario. Surya Consumer Goods Ltd. manufactures personal-care and household FMCG products. A competitor study identifies three broad strategic clusters. Premium brands generally command higher prices, invest substantially in product differentiation and brand-building, and often rely on selective distribution through premium retail outlets. Budget brands operate with lower prices, standardised products, high-volume economics and extensive mass-market distribution. Mid-market brands occupy an intermediate position on price and differentiation. Surya currently competes primarily in the budget cluster but is considering entering the premium cluster. Management recognises that the two groups differ not merely in selling price but also in brand identity, product quality perceptions, marketing capability, customer expectations and distribution relationships.

Surya Consumer Goods Ltd. wants to map the strategic groups in its FMCG industry. Which pair of mapping dimensions would most directly distinguish the premium and budget competitive clusters described in the scenario?

1. Company age and number of employees, because older and larger firms necessarily belong to the premium group.
2. Total annual revenue and geographical location, because a larger geographic presence automatically indicates a premium competitive strategy.
3. Average product price and distribution breadth, because the premium and budget clusters differ in their pricing positions and distribution approaches. (correct answer)
4. Number of factories and accounting profit, because manufacturing capacity alone determines how a firm competes with customers.

Answer: C — Average product price and distribution breadth, because the premium and budget clusters differ in their pricing positions and distribution approaches.

Working. Step 1: Identify the competitive differences in the scenario: price, product differentiation and distribution approach. Step 2: Select two dimensions that directly distinguish the identified clusters. Step 3: Use average product price on one axis and distribution breadth on the other. Step 4: Position premium brands in the higher-price, selective-distribution region and budget brands in the lower-price, mass-distribution region. The map therefore identifies distinct competitive clusters.

Explanation. Option (c) is correct. Strategic group analysis identifies competitors that follow broadly similar competitive approaches. In the given case, product price and distribution breadth are meaningful dimensions because the premium cluster commands higher prices and tends to use selective distribution, while the budget cluster competes through lower prices and extensive mass-market distribution. A strategic group map can make these differences visible and help management understand competitive positioning. Option (a) uses organisational characteristics that do not directly explain the competitive approach described. Option (b) confuses company scale and geographic presence with its pricing and differentiation strategy. Option (d) focuses on internal manufacturing and financial characteristics rather than the dimensions that distinguish the competitive clusters in this scenario.

Where it goes wrong. Do not select mapping dimensions merely because information is readily available. The chosen dimensions should differentiate competitors according to their competitive approaches and market positions. Two companies may have similar size or revenue but belong to different strategic groups.

Authority. Chapter 2: Strategic Analysis: External Environment, Section 2.2 Strategic Analysis - External Analysis: Competitor Analysis and Strategic Groups; Chapter 2: Strategic Analysis: External Environment, Section 2.7.1 Competitive Landscape

Question 8 · 1 marks · Strategic Analysis: External Environment - Strategic Groups and Barriers to Entry · medium

Surya Consumer Goods Ltd. wants to move from the budget FMCG strategic group into the premium group. Which combination represents the most significant barriers to such movement?

1. Offering short-term discounts and increasing sales volume through the existing mass-market channels.
2. Increasing production through the existing low-cost process without changing product quality or customer perception.
3. Reducing packaging costs while retaining the existing brand identity and undifferentiated product range.
4. Building a credible premium brand identity, developing differentiated product quality and obtaining access to suitable premium distribution channels. (correct answer)

Answer: D — Building a credible premium brand identity, developing differentiated product quality and obtaining access to suitable premium distribution channels.

Working. Step 1: Identify the target strategic group: premium FMCG brands. Step 2: Compare it with the current budget group's competitive approach. Step 3: Identify the required strategic changes: premium brand identity, differentiated product quality and access to suitable premium channels. Step 4: Recognise that these changes require resources, investment and customer acceptance, making them obstacles to movement between strategic groups. Therefore, option (d) identifies the relevant combination.

Explanation. Option (d) is correct. Moving from a budget to a premium strategic group requires more than changing the selling price. Premium positioning requires credible brand identity, meaningful product differentiation and the ability to access distribution channels suited to the target customer segment. Option (a) may increase short-term sales but reinforces the existing low-price approach and does not create premium positioning. Option (b) improves capacity or cost efficiency but leaves the key quality and customer-perception differences unresolved. Option (c) reinforces a cost-oriented approach and does not establish differentiation or premium brand credibility. The ICAI chapter discusses strategic groups within competitor analysis and separately identifies product differentiation, brand identity and access to distribution channels as barriers to entry. Applying those factors to movement between strategic groups is the analytical basis of this question; mobility barriers are not presented as a separate standalone section in the supplied chapter.

Where it goes wrong. A higher selling price alone does not create a premium strategic position. A firm must establish customer-perceived differentiation, a credible brand identity and appropriate market access. Do not confuse a temporary pricing change with a sustainable change in competitive positioning.

Authority. Chapter 2: Strategic Analysis: External Environment, Section 2.2 Strategic Analysis - Competitor Analysis: Strategic Groups; Chapter 2: Strategic Analysis: External Environment, Section 2.5.1 Porter's Five Forces Model - I. Threat of New Entrants: Barriers to Entry